Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Mad Money Lightning Round: Chevron, Nokia, Pioneer Natural Resources
By Scott Rutt
May 22, 2021 7:30 AM EDT
Latest News
JIM CRAMER
Mad Money Lightning Round: Chevron, Nokia, Pioneer Natural Resources
By Scott Rutt
May 22, 2021 7:30 AM EDT
JIM CRAMER
Cramer's Mad Money Recap: Lordstown Motors, Intuit, Costco
By Scott Rutt
May 21, 2021 8:23 PM EDT
PRESS RELEASES
Major League Soccer Renews With BioReference Laboratories As COVID-19 Testing Provider For Second Year
By PR Newswire
Apr 27, 2021 8:38 AM EDT
PRESS RELEASES
OPKO Health To Report First Quarter 2021 Financial Results On April 28, 2021
By GlobeNewswire
Apr 22, 2021 8:00 AM EDT
PRESS RELEASES
BioReference Laboratories Expands Its Major League Sports Relationships With Addition Of Major League Baseball
By PR Newswire
Apr 1, 2021 8:28 AM EDT
PRESS RELEASES
BioReference Laboratories Expands COVID-19 School Testing Program
By PR Newswire
Mar 26, 2021 8:25 AM EDT
PRESS RELEASES
EMA Accepts Marketing Application For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency
By Business Wire
Feb 26, 2021 6:30 AM EST
PRESS RELEASES
OPKO Health To Report Fourth Quarter 2020 Financial Results On February 18, 2021
By GlobeNewswire
Feb 3, 2021 9:01 AM EST
PRESS RELEASES
New Drug Application Submitted To PMDA In Japan For Somatrogon, To Treat Pediatric Patients With Growth Hormone Deficiency
By GlobeNewswire
Jan 28, 2021 8:00 AM EST
PRESS RELEASES
OPKO Health's BioReference Laboratories Team-up With The National Basketball Association And National Hockey League To Provide Players And Staff With COVID-19 Testing
By PR Newswire
Jan 26, 2021 8:00 AM EST
JIM CRAMER
Mad Money Recap With Jim Cramer: A Plan for Earnings Season
By Scott Rutt
Jan 16, 2021 12:37 PM EST
PRESS RELEASES
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, An In-Home Diagnostic Service To Expand Digital Health Access
By PR Newswire
Jan 13, 2021 3:40 PM EST
PRESS RELEASES
OPKO Health To Present At The 39th Annual J.P. Morgan Healthcare Conference
By GlobeNewswire
Jan 5, 2021 8:00 AM EST
PRESS RELEASES
OPKO Health's BioReference Laboratories Reports Results Of The Largest COVID-19 Public School Testing Program Nationwide
By PR Newswire
Jan 4, 2021 12:05 PM EST
PRESS RELEASES
Buffalo Bills And OPKO Health's BioReference Laboratories Initiate The First Large Scale, Mandatory COVID-19 Fan Testing Program
By PR Newswire
Dec 31, 2020 8:30 AM EST
PRESS RELEASES
OPKO Health Appoints Dr. Roger Medel To Its Board Of Directors
By GlobeNewswire
Dec 21, 2020 8:00 AM EST
STOCKS
10 Best Stocks Under $10 This Past Week: BlackBerry Soars
By Danny Peterson
Dec 7, 2020 8:54 AM EST
PRESS RELEASES
OPKO Health To Participate In Three Upcoming Investment Conferences
By GlobeNewswire
Nov 11, 2020 9:10 AM EST
PRESS RELEASES
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 And Influenza A/B Test
By PR Newswire
Oct 20, 2020 8:00 AM EDT
PRESS RELEASES
OPKO Health To Report Third Quarter 2020 Financial Results On October 29, 2020
By GlobeNewswire
Oct 13, 2020 12:50 PM EDT
PRESS RELEASES
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program For New York City Schools
By PR Newswire
Oct 9, 2020 8:00 AM EDT
PRESS RELEASES
Pfizer Announces Positive Phase 3 Top-line Results For Once-Weekly Investigational Long-Acting Human Growth Hormone To Treat Children With Growth Hormone Deficiency
By Business Wire
Oct 8, 2020 6:45 AM EDT
JIM CRAMER
Trick or Tweet: Cramer's 'Mad Money' Recap (Wednesday 10/7/20)
By Scott Rutt
Oct 7, 2020 9:09 PM EDT
INVESTING
Opko Shares Climb on Phase 2 Trial of Coronavirus Treatment
By Tony Owusu
Sep 15, 2020 9:05 AM EDT
